Series on Diabetes and Cardiovascular Disease
Diabetes remains an important risk factor for cardiovascular disease as well as important marker and modifier of risk in the hospitalized patient. Despite our longstanding knowledge of the impact of diabetes on the natural history of cardiovascular disease, our ability to modify specific aspects of diabetes remains limited.
Accordingly, in this Circulation Series on Diabetes and Cardiovascular Disease, a group of experts have provided review articles in the following content areas. The first three articles will review the role of intensive glucose lowering in the outpatient and inpatient setting, as well as a review dedicated to the primary side effect of glucose-lowering therapy, hypoglycemia. The second set of articles will review the impact of diabetes on antiplatelet therapy and revascularization. Finally, the third set of articles will review cardiovascular risk stratification in the patient with diabetes, and finally, the role of regulatory agencies in the assessment of cardiovascular outcomes among users of antidiabetic agents. I am grateful to the authors of this series, who are attempting to make sense of a rapidly evolving field that has often yielded more questions than answers.
- © 2010 American Heart Association, Inc.